title: [Identifying myocardial ischaemia in diabetics. SFC/ALFEDIAM joint recommendations].
authors.affiliation: Société française de cardiologie.
authors.forename: J
authors.initials: J
authors.lastname: Puel
authors.forename: P
authors.initials: P
authors.lastname: Valensi
authors.forename: G
authors.initials: G
authors.lastname: Vanzetto
authors.forename: V
authors.initials: V
authors.lastname: Lassmann-Vague
authors.forename: J L
authors.initials: JL
authors.lastname: Monin
authors.forename: P
authors.initials: P
authors.lastname: Moulin
authors.forename: C
authors.initials: C
authors.lastname: Ziccarelli
authors.forename: H
authors.initials: H
authors.lastname: Mayaudon
authors.forename: M
authors.initials: M
authors.lastname: Ovize
authors.forename: S
authors.initials: S
authors.lastname: Bernard
authors.forename: E
authors.initials: E
authors.lastname: Van Belle
authors.forename: S
authors.initials: S
authors.lastname: Halimi
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000150:complications; D023921:Coronary Stenosis / Q000150:complications; D003925:Diabetic Angiopathies / Q000150:complications* / Q000517:prevention & control; D005602:France; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000150:complications* / Q000175:diagnosis* / Q000628:therapy; D009204:Myocardial Revascularization; D012307:Risk Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors